🔎 Trials Near Me

Home › Atherosclerosis › Virginia › Arlington

Atherosclerosis clinical trials in Arlington, VA

8 studies for Atherosclerosis are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

RecruitingPhase 2
  • Carient Heart and Vascular LLC-Reston, Reston · 14 mi away
  • Carient Heart & Vascular - Manassas, Manassas · 22 mi away
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07783802

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

RecruitingPhase 3
  • Virginia Heart, Falls Church · 4 mi away
  • Carient Heart and Vascular LLC-Reston, Reston · 14 mi away
  • Carient Heart & Vascular - Manassas, Manassas · 22 mi away
  • and 1 more
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RecruitingPhase 3
  • Virginia Heart, Falls Church · 4 mi away
  • Inova Cardiology - Fairfax, Fairfax · 11 mi away
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

RecruitingPhase 3
  • Virginia Heart, Falls Church · 4 mi away
Ages 45 to 80 · All sexes · Updated Sep 22, 2026 · NCT07613294

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

RecruitingPhase 2/3
  • Nephrology Associates of Northern Virginia Inc, Fairfax · 11 mi away
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

RecruitingPhase 3
  • Research Site, Falls Church · 4 mi away
  • Research Site, Fairfax · 11 mi away
  • Research Site, Manassas · 22 mi away
  • and 1 more
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

RecruitingPhase 3
  • Virginia Heart, Falls Church · 4 mi away
Ages 18 to 80 · All sexes · Updated Aug 7, 2026 · NCT06813911

Pelacarsen Roll-over Extension Program

RecruitingPhase 3
  • Virginia Heart, Falls Church · 4 mi away
Ages 18 to 100 · All sexes · Updated Jul 29, 2026 · NCT06875973

About Atherosclerosis

Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.

More about Atherosclerosis on MedlinePlus

Atherosclerosis trials in other cities

Other studies in Arlington

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.